ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,295,396 | -36.4% | 420,372 | -15.5% | 0.04% | -42.6% |
| Q2 2023 | $17,750,050 | +65.1% | 497,758 | +17.6% | 0.06% | +60.5% |
| Q1 2023 | $10,751,998 | +1987.8% | 423,307 | +2795.6% | 0.04% | +1800.0% |
| Q2 2022 | $515,000 | -91.4% | 14,619 | -88.7% | 0.00% | -88.2% |
| Q1 2022 | $5,965,000 | +974.8% | 129,701 | +1450.5% | 0.02% | +750.0% |
| Q4 2021 | $555,000 | -26.6% | 8,365 | -30.9% | 0.00% | 0.0% |
| Q3 2021 | $756,000 | +108.8% | 12,109 | +112.2% | 0.00% | 0.0% |
| Q4 2019 | $362,000 | – | 5,706 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |